drugset / Trial / NCT02168309

Oral Nifedipine Versus Oral Labetalol

NCT02168309

Completed 50 enrolled Cedars-Sinai Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This study's aim is to determine whether oral extended release nifedipine is superior to oral labetolol for the management of postpartum severe hypertension, specifically time to achieve goal blood pressure, and shortening hospital stay. Our hypothesis is that oral extended release nifedipine is superior to oral labetolol for achieving goal blood pressure in the postpartum period.

Timeline

Start
2014-06
Primary completion
2015-06
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Labetalol Small molecule 200 mg Oral
Subject Nifedipine Other / unclassified 30 mg Oral